JOURNAL ARTICLE

Foslevodopa/foscarbidopa: a new subcutaneous treatment for Parkinson's disease

Matthew Rosebraugh, Eric A Voight, Ehab M Moussa, Feroz Jameel, Xiaochun Lou, Geoff G Z Zhang, Peter T Mayer, Deanne Stolarik, Robert A Carr, Brian P Enright, Wei Liu, Maurizio F Facheris, Philip R Kym
Annals of Neurology 2021 March 26
33772855

OBJECTIVE: To demonstrate that continuous subcutaneous infusion of a soluble levodopa (LD)/carbidopa (CD) phosphate prodrug combination effectively delivers stable LD exposure via a minimally invasive and convenient mode and has the potential to treat Parkinson's disease (PD) patients who are not well controlled on oral medication.

METHODS: Foslevodopa/foscarbidopa are prepared and equilibrium solubility and chemical stability are examined in aqueous media of different pHs. Solutions of foslevodopa/foscarbidopa (4:1 to 20:1 ratios) were prepared by dissolving pH-adjusted lyophilized materials in water and infused subcutaneously in healthy volunteers for up to 72 hours. Frequent blood samples were collected to measure LD and CD exposure and safety was monitored throughout the study.

RESULTS: Foslevodopa/foscarbidopa (ABBV-951), demonstrates high water solubility and excellent chemical stability near physiological pH enabling continuous subcutaneous infusion therapy. Following subcutaneous infusion, a stable LD pharmacokinetic (PK) profile was maintained for up to 72 hours and the infusion was well tolerated.

INTERPRETATION: Preparation of foslevodopa and foscarbidopa enables preclinical and clinical PK, safety, and tolerability studies in support of their advancement for the treatment of PD. In Phase 1 clinical trials, foslevodopa/foscarbidopa demonstrates consistent and stable LD plasma exposure supporting further studies of this treatment as a potentially transformational option for those suffering from PD. This article is protected by copyright. All rights reserved.

Full Text Links

We have located links that may give you full text access.

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

Remove bar
Read by QxMD icon Read
33772855
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"